NCT02597036 2025-10-23
A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors
Eli Lilly and Company
Phase 1 Terminated
Clinical Trials
4 trialsNCT04557384 2023-02-27
A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer
Eli Lilly and Company
Phase 1 Terminated
NCT01682135 2016-08-26
A Study in Participants With Advanced Solid Tumors
Eli Lilly and Company
Phase 1 Completed
NCT01005355 2014-06-18
Study of IMC-1121B in Patients With Advanced Solid Tumors
Eli Lilly and Company
Phase 1 Completed